Trust Bio-sonics, Inc. Taiwan

Developing the medical applications of bubble technologies, and seeking the advantages of Contrast-enhanced Ultrasound Imaging (CEUS). We serve with the advanced ultrasound contrast agents for research purposes. Currently under clinical developments of our microbubble product. The target indications would be focal liver lesion detection, breast cancer detection, and CAD perfusion imaging. Furthermore, we aim to develop the ultrasound-triggered release system and make it available in clinical practices.

Dr Chung-Hsin Wang
Dr Chung-Hsin Wang
CEO